相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting GATA4 for cardiac repair
Mika J. Valimaki et al.
IUBMB LIFE (2020)
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang et al.
MOLECULAR CANCER (2019)
Bioactive Sphingolipids as Biomarkers Predictive of Disease Severity and Treatment Response in Cancer: Current Status and Translational Challenges
Mirela Sedic et al.
ANTICANCER RESEARCH (2019)
Apolipoprotein M and sphingosine-1-phosphate complex alleviates TNF-α-induced endothelial cell injury and inflammation through PI3K/AKT signaling pathway
Yang Liu et al.
BMC CARDIOVASCULAR DISORDERS (2019)
Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases
Elena M. G. Diarte-Anazco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Sphingosine-1-phosphate promotes the proliferation and attenuates apoptosis of Endothelial progenitor cells via S1PR1/S1PR3/PI3K/Akt pathway
Hang Wang et al.
CELL BIOLOGY INTERNATIONAL (2018)
Asiatic acid attenuates CCl4-induced liver fibrosis in rats by regulating the PI3K/AKT/mTOR and Bcl-2/Bax signaling pathways
Liwen Wei et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
Jessica Lawrence et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Bioactive Sphingolipids, Complement Cascade, and Free Hemoglobin Levels in Stable Coronary Artery Disease and Acute Myocardial Infarction
T. Jadczyk et al.
MEDIATORS OF INFLAMMATION (2018)
Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate
Yuko Mishima et al.
BIOSCIENCE REPORTS (2018)
Metabolic remodelling in heart failure revisited
Miranda Nabben et al.
NATURE REVIEWS CARDIOLOGY (2018)
A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling
Leonardo Schirone et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Characterization and Expression of Sphingosine 1-Phosphate Receptors in Human and Rat Heart
Naseer Ahmed et al.
FRONTIERS IN PHARMACOLOGY (2017)
Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6
Sei-ichiro Ohkura et al.
PLOS ONE (2017)
Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis
Han-Shui Hsu et al.
SCIENTIFIC REPORTS (2017)
PI3K and Calcium Signaling in Cardiovascular Disease
Alessandra Ghigo et al.
CIRCULATION RESEARCH (2017)
Transforming growth factor--sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells
Xiujuan Liu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis
Yen-Sin Ang et al.
CELL (2016)
Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure
Alessio Galli et al.
CARDIOLOGY RESEARCH AND PRACTICE (2016)
Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis
Feng Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity
S. Rodriguez-Cuenca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Pharmacological Inhibition of PI3K Reduces Adiposity and Metabolic Syndrome in Obese Mice and Rhesus Monkeys
Ana Ortega-Molina et al.
CELL METABOLISM (2015)
Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy
Jason Newton et al.
EXPERIMENTAL CELL RESEARCH (2015)
Switching the Sphingolipid Rheostat in the Treatment of Diabetes and Cancer Comorbidity from a Problem to an Advantage
Nikolas K. Haass et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The GSK-3 Family as Therapeutic Target for Myocardial Diseases
Hind Lal et al.
CIRCULATION RESEARCH (2015)
GSK-3-at the crossroads of cell death and survival
Ulrich Maurer et al.
JOURNAL OF CELL SCIENCE (2014)
Vertical inhibition of PI3K/Akt/mTOR signaling demonstrates in vitro and in vivo anti-fibrotic activity
Minrui Liang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Sphingosine-1-phosphate: A Janus-faced mediator of fibrotic diseases
Stephanie Schwalm et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
β1-Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and Progression to Heart Failure Protective Role of S1PR1 Cardiac Gene Therapy
Alessandro Cannavo et al.
CIRCULATION (2013)
Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury
Emmanuel E. Egom et al.
FRONTIERS IN PHYSIOLOGY (2013)
Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat
Malgorzata Knapp et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide
Qing Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Myocardial Infarction Changes Sphingolipid Metabolism in the Uninfarcted Ventricular Wall of the Rat
Malgorzata Knapp et al.
LIPIDS (2012)
β-MyHC and Cardiac Hypertrophy Size Does Matter
Kumar Pandya et al.
CIRCULATION RESEARCH (2011)
Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Toshinori Aoyagi et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease
Kelley M. Argraves et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Sphingosine-1-Phosphate Activates the AKT Pathway to Protect Small Intestines from Radiation-Induced Endothelial Apoptosis
Stephanie Bonnaud et al.
CANCER RESEARCH (2010)
Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?
Suree Lekawanvijit et al.
EUROPEAN HEART JOURNAL (2010)
Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation
Sang Won Park et al.
LABORATORY INVESTIGATION (2010)
The Akt-SREBP nexus: cell signaling meets lipid metabolism
James R. Krycer et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Sphingosine-1-phosphate receptor signalling in the heart
Christopher K. Means et al.
CARDIOVASCULAR RESEARCH (2009)
GATA4, a new regulator of cardiac fibroblasts, is sensitive to natriuretic peptides
Marek Jankowski
CARDIOVASCULAR RESEARCH (2009)
Deletion of GSK-3β in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation
Risto Kerkela et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
The role of natriuretic peptides in cardioprotection
T Nishikimi et al.
CARDIOVASCULAR RESEARCH (2006)
mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events
MK Holz et al.
CELL (2005)
Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry
EV Berdyshev et al.
ANALYTICAL BIOCHEMISTRY (2005)
Putting the brakes on cardiac hypertrophy - Exploiting the NO-cGMP counter-regulatory system
GW Booz
HYPERTENSION (2005)
Phosphorylation of eukaryotic translation initiation factor 2Bε by glycogen synthase kinase-3β regulates β-adrenergic cardiac myocyte hypertrophy
SE Hardt et al.
CIRCULATION RESEARCH (2004)
The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis
M Kono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
mTOR-Dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF
KM Hannan et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
α-actin isoform distribution in normal and failing human heart:: a morphological, morphometric, and biochemical study
AJH Suurmeijer et al.
JOURNAL OF PATHOLOGY (2003)
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes
P Robert et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2001)
Glycogen synthase kinase 3β regulates GATA4 in cardiac myocytes
C Morisco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy
S Haq et al.
JOURNAL OF CELL BIOLOGY (2000)
The Akt-glycogen synthase kinase 3β pathway regulates transcription of atrial natriuretic factor induced by β-adrenergic receptor stimulation in cardiac myocytes
C Morisco et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
